PATENT CLAIM ANALYSIS

Application Number: 16184499
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-04
Patent Classification: ["435", "007320"]

Abstract:
The present application concerns a method for identifying the nature of a bacterial infection from a peritoneal sample, in particular, whether it is a Gram-negative or Gram-positive infection, based upon the determination of one or more cellular and/or humoral markers in a sample.

Claim (Index 6):
The method according to  claim 1  wherein said therapeutic is selected from the list comprising:\n penicillins and beta-lactamase inhibitors, cephalosporins, macrolides and lincosamines, quinolones and fluoroquinolones, carbapenems, monobactams, aminoglycosides, tetracyclines, sulfonamides, rifampin, oxazolidonones, all macrolides, all polymixins, all quinolones, all glycopeptides, all lincosamides, all streptomycin derivatives, and all antibiotics not covered by generic classes including chloramphenicol, rifampicin, fosfomycin, fosmidomycin, nitrofurantoin, metronidazole, daptomycin, quinupristin, linezolid, telavancin, mupirocin, and folate synthesis inhibitors as well as structural analogues and derivates thereof.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 98.0
- Lexical Diversity: 1.34286
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14775738', '14372629', '15031610', '13264255', '09889324']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.529148308383414
- 35 USC 102 Novelty (BERT): 0.6307821717131882
- Combined Prediction Score: 0.5393116947163914
- Mean Citation Score: 300.711336
- Max Citation Score: 602.1517299999998
- Similarity Product: 532.0925635475277

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test